PMID: 2121811Nov 1, 1990Paper

Automatic implantable cardioverter-defibrillator: is early implantation cost-effective?

Journal of the American College of Cardiology
S O'DonoghueL Mispireta

Abstract

The evaluation of survivors of sudden cardiac death with serial electrophysiologic studies involves a lengthy and expensive hospitalization, especially when an automatic implantable cardioverter-defibrillator is ultimately necessary. The cost efficacy of this conventional approach was therefore compared with direct implantation of a cardioverter-defibrillator after the first electrophysiologic study. Thirty-two survivors of sudden death who had inducible ventricular tachycardia during their initial electrophysiologic study underwent serial drug trials. At discharge 12 (37%) were taking an antiarrhythmic drug found to prevent induction of ventricular tachycardia and 20 underwent cardioverter-defibrillator implantation after serial drug trials proved ineffective. The average length of hospitalization for this group that had undergone serial drug testing was 20.2 +/- 9.3 days at an average cost of $48,900 +/- $31,600. Seven survivors of sudden death had no inducible ventricular tachycardia during their initial electrophysiologic study and underwent direct cardioverter-defibrillator implantation. Their average length of hospitalization was 12.6 +/- 6.2 days at an average cost of $40,400 +/- $8,300. It is concluded that automatic im...Continue Reading

References

Jun 1, 1987·Journal of the American College of Cardiology·M D GabryS Furman
Nov 1, 1984·Pacing and Clinical Electrophysiology : PACE·M MirowskiJ M Juanteguy

❮ Previous
Next ❯

Citations

Mar 1, 1997·Herzschrittmachertherapie & Elektrophysiologie·R K Reddy, G H Bardy
Dec 1, 1996·The American Journal of Cardiology·D S CardinalL Foley
Mar 1, 1995·Progress in Cardiovascular Diseases·J KupersmithJ Gardiner
Apr 1, 1992·Pacing and Clinical Electrophysiology : PACE·J FarréG Rábago
Mar 1, 1993·Pacing and Clinical Electrophysiology : PACE·R N HauerH J Crijns
Mar 1, 1993·Pacing and Clinical Electrophysiology : PACE·R G Hauser
Dec 1, 1994·Pacing and Clinical Electrophysiology : PACE·B D WilliamsonF Morady
Apr 1, 1995·Pacing and Clinical Electrophysiology : PACE·F J VendittiD M Shahian
Feb 1, 1997·Pacing and Clinical Electrophysiology : PACE·R K Reddy, G H Bardy
Dec 1, 1995·Controlled Clinical Trials·N R Powe, R I Griffiths
Sep 12, 1996·The American Journal of Cardiology·R N HauerE F Wever
Jan 1, 1993·The American Journal of Cardiology·T E KottkeS C Hammill
Aug 1, 1994·Pacing and Clinical Electrophysiology : PACE·D L JonesF Varin
Apr 1, 1993·Circulation·G H BardyD Kelso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.